Advancing the science of what’s next
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and
ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.
Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technologies. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including ZymoGenetics, Immunex, Dendreon, Pfizer, VLST, MedImmune and more.
Our proprietary platforms and therapeutic candidates help position us to enter potential partnering and licensing arrangements, which may include upfront fees, development milestones, royalties and other compensation.
At Aptevo Therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology.